Oncology & Cancer

Early prostate cancers can harbor aggressive tumor cells

Many cases of early prostate cancer are dominated by cells that are slow-growing, often leading to a clinical decision to monitor for progression before initiating treatments that can have adverse side effects.

Vaccination

What's at stake in COVID-19 jab patent waiver row

Over a year into global COVID-19 vaccination efforts the question of whether jab formulas ought to be freely available is still unresolved—and undersupplied countries are turning to workarounds.

Biomedical technology

Bone-building cells favor different orthopedic implant designs

New orthopedic implant devices that promote faster healing and ultimately reduce the strain on the NHS could be available in the future thanks to new research by Loughborough University engineering experts that reveals which ...

Vaccination

Optimization of mRNA containing nanoparticles

The research neutron source Hein Maier-Leibnitz (FRM II) at the Technical University of Munich (TUM) is playing an important role in the investigation of mRNA nanoparticles similar to the ones used in the COVID-19 vaccines ...

page 14 from 40